Skip to search formSkip to main contentSkip to account menu

LY500307

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract 1163: Estrogen receptor beta (ESR2)-mediated tumor suppression of glioblastoma involves modulation of cell cycle and DNA damage response pathways
Purpose: Glioblastomas (GBM) are deadly brain tumors, have greater incidence in males than females. Epidemiological evidence… 
2015
2015
Abstract 951: LY500307 as a novel therapeutic agent for treatment of glioblastoma
Glioblastoma (GBM) is the most common type of primary brain tumor with poor prognosis. A gender bias exists in the development of… 
2014
2014
Abstract 606: Therapeutic efficacy of ERβ agonists on ovarian cancer
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Ovarian cancer (OC) is the deadliest of all gynecologic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)